BTIG reiterates Buy on Verastem, $18 price target
BTIG reiterated a Buy rating on Verastem and set a $18.00 price target, implying upside versus the Oct 7 close of $8.27.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
BTIG reiterated a Buy rating on Verastem and set a $18.00 price target, implying upside versus the Oct 7 close of $8.27.
BTIG reiterated its Buy rating on Verastem and maintained a price target of $18.00, suggesting a potential upside of 133.8% from the previous closing price.